# Training–Fuel Coupling (TFC): A Molecular Sports Nutrition Framework for Energy Availability, Chrono-Nutrition, and Performance Optimization

**Authors:** Mirela Stoian, Dan Cristian Mănescu

PMC · DOI: 10.3390/nu18040693 · 2026-02-21

## TL;DR

This paper introduces a new framework called Training–Fuel Coupling (TFC) that explains how nutrition and exercise interact at the molecular level to optimize athletic performance.

## Contribution

The paper proposes TFC as a novel systems physiology framework linking nutrient availability, timing, and exercise adaptation.

## Key findings

- AMPK and mTOR signaling pathways are modulated by energy availability, influencing metabolic flexibility and recovery.
- Alternating between low-energy and nutrient-replete states may enhance adaptive efficiency through oscillatory signaling.
- TFC offers a hypothesis-generating model for managing energy availability and preventing maladaptive states like RED-S.

## Abstract

In sports nutrition, performance adaptation emerges from the coordinated molecular interaction between physical training and nutrient availability. This narrative review with conceptual synthesis advances Training–Fuel Coupling (TFC) as a systems physiology framework that conceptualizes nutrient availability, timing, and recovery feeding as molecular control variables proposed to govern exercise-induced adaptation. Integrating evidence from exercise metabolism and nutritional science, the model conceptualizes how substrate availability may modulate the dynamic crosstalk between AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR), shaping metabolic flexibility, anabolic recovery, and long-term performance optimization. Low-energy and low-glycogen contexts preferentially activate AMPK-dependent pathways supporting mitochondrial remodeling and oxidative efficiency, whereas nutrient-replete states facilitate mTOR-mediated protein synthesis and structural restoration. When strategically alternated through chrono-nutrition and nutritional periodization, these energetic states are hypothesized to generate oscillatory signaling patterns that enhance adaptive efficiency while limiting chronic metabolic strain. From a sports nutrition perspective, TFC provides a mechanistic rationale for energy availability management, recovery nutrition, and the prevention of maladaptive states such as Relative Energy Deficiency in Sport (RED-S). By reframing nutrients as regulatory signals rather than passive fuel, this framework integrates molecular nutrition with performance physiology, offering a unifying, systems-level and hypothesis-generating perspective on training–nutrition interactions that delineates testable pathways for future empirical investigation.

## Full-text entities

- **Genes:** PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, CS (citrate synthase) [NCBI Gene 1431], PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, RPTOR (regulatory associated protein of MTOR complex 1) [NCBI Gene 57521] {aka KOG1, Mip1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TSC2 (TSC complex subunit 2) [NCBI Gene 7249] {aka LAM, PPP1R160, TSC4}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** fatigue (MESH:D005221), TFC (MESH:D000095027), muscle hypertrophy (MESH:C536106), Energy Deficiency in Sport (MESH:D000080822), metabolic syndrome (MESH:D024821), inflammation (MESH:D007249), sarcopenia (MESH:D055948), injury to (MESH:D014947), endocrine disruption (MESH:D004700), hypertrophy (MESH:D006984)
- **Chemicals:** Glycogen (MESH:D006003), lipid (MESH:D008055), steroid (MESH:D013256), ATP (MESH:D000255), AMP (MESH:D000249), leucine (MESH:D007930), Reactive oxygen species (MESH:D017382), glucose (MESH:D005947), essential amino acid (MESH:D000601), NAD+ (MESH:D009243), O2 (MESH:D010100), H2 (-), carbohydrate (MESH:D002241), amino acid (MESH:D000596), catecholamine (MESH:D002395), Lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943547/full.md

---
Source: https://tomesphere.com/paper/PMC12943547